Analysts' ratings for Inari Medical (NASDAQ:NARI) over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table encapsulates their recent ratings, offering a ...

Oppenheimer initiated coverage of Inari Medical (NARI) with an Outperform rating and $75 price target Inari is a leader in the thrombectomy for the treatment of deep vein thrombosis and pulmonary ...

We recently compiled a list of the Investor Optimism Boosts Jump of These 10 Stocks. In this article, we are going to take a ...

Stryker announces agreement to acquire Inari Medical for $4.9 billion, resulting in a 21% jump in Inari's shares.

Inari Medical's stock surged 6% amid reports of advanced acquisition talks with Stryker, potentially closing a deal this week ...

Despite a lackluster performance from Wall Street’s major indices, 10 companies demonstrated notable resilience.

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report)’s share price traded down 4.6% during mid-day trading on Monday after an insider sold shares in the company.The stock traded as low as $52. ...

NASDAQ:NARI opened at $54.41 on Tuesday. The stock has a market cap of $3.19 billion, a price-to-earnings ratio of -40.30 and a beta of 0.97. Inari Medical has a one year low of $36.73 and a one ...